Skip to content

Author

Ming-Hong Chen

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Ferroptosis Inhibitor Liproxstatin-1 Alleviates Triptolide-Induced Blood Testis-Barrier Disruption and Testicular Injury.

Triptolide (TP), the principal bioactive component of Tripterygium wilfordii (T. wilfordii), exhibits potent pharmacological activities; however, its clinical application is limited by severe male reproductive toxicity, and effective interventions to mitigate reproductive toxicity remain limited. Although the relations...

Songxia Lin, Jianxun Song, Xiao-Dan Wang et al. · 0 citations
Review Open access Aug 2026

The Crosstalk Between YAP/TAZ and Cancer Metabolism: From Mechanistic Insights to Drug Discovery

The interplay between YAP/TAZ and metabolic reprogramming in cancer is systematically clarified, the core molecular networks through which YAP/TAZ govern each metabolic pathway are delineated, and the current pharmacological inhibitors targeting YAP/TAZ-regulated metabolic networks are summarized.

Yin-Huang Gao, Ming-Hong Chen, Song-Xia Lin et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.